N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine

C69H71F6N27 — CID 158195493

IUPACN-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine
SMILESCCc1cc(Nc2nncc(-n3ccnc3)n2)n[nH]1.FC(F)(F)c1ccccc1-c1cc(Nc2n[nH]c3ccccc23)nnc1NCCN1CCCCC1.FC(F)(F)c1ccccc1-c1cnnc(Nc2n[nH]c3ccccc23)c1.c1nnc(Nc2cc(C3CCCC3)[nH]n2)nc1N1CCCC1
InChIInChI=1S/C25H26F3N7.C18H12F3N5.C15H21N7.C11H12N8/c26-25(27,28)20-10-4-2-8-17(20)19-16-22(30-24-18-9-3-5-11-21(18)31-34-24)32-33-23(19)29-12-15-35-13-6-1-7-14-35;19-18(20,21)14-7-3-1-5-12(14)11-9-16(25-22-10-11)23-17-13-6-2-4-8-15(13)24-26-17;1-2-6-11(5-1)12-9-13(20-19-12)17-15-18-14(10-16-21-15)22-7-3-4-8-22;1-2-8-5-9(17-16-8)14-11-15-10(6-13-18-11)19-4-3-12-7-19/h2-5,8-11,16H,1,6-7,12-15H2,(H,29,33)(H2,30,31,32,34);1-10H,(H2,23,24,25,26);9-11H,1-8H2,(H2,17,18,19,20,21);3-7H,2H2,1H3,(H2,14,15,16,17,18)
InChIKeyGAHFUKJFPSODTH-UHFFFAOYSA-N
MW1392.50 g/mol
LogP14.14
Rot. Bonds18

About N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine

N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine (PubChem CID 158195493) has the molecular formula C69H71F6N27 and a molecular weight of 1392.50 g/mol. Its IUPAC name is N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine.

Molecular Properties

Compound NameN-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine
PubChem CID158195493
Molecular FormulaC69H71F6N27
Molecular Weight1392.50 g/mol
Exact Mass1391.63
IUPAC NameN-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine
SMILESCCc1cc(Nc2nncc(-n3ccnc3)n2)n[nH]1.FC(F)(F)c1ccccc1-c1cc(Nc2n[nH]c3ccccc23)nnc1NCCN1CCCCC1.FC(F)(F)c1ccccc1-c1cnnc(Nc2n[nH]c3ccccc23)c1.c1nnc(Nc2cc(C3CCCC3)[nH]n2)nc1N1CCCC1
InChIInChI=1S/C25H26F3N7.C18H12F3N5.C15H21N7.C11H12N8/c26-25(27,28)20-10-4-2-8-17(20)19-16-22(30-24-18-9-3-5-11-21(18)31-34-24)32-33-23(19)29-12-15-35-13-6-1-7-14-35;19-18(20,21)14-7-3-1-5-12(14)11-9-16(25-22-10-11)23-17-13-6-2-4-8-15(13)24-26-17;1-2-6-11(5-1)12-9-13(20-19-12)17-15-18-14(10-16-21-15)22-7-3-4-8-22;1-2-8-5-9(17-16-8)14-11-15-10(6-13-18-11)19-4-3-12-7-19/h2-5,8-11,16H,1,6-7,12-15H2,(H,29,33)(H2,30,31,32,34);1-10H,(H2,23,24,25,26);9-11H,1-8H2,(H2,17,18,19,20,21);3-7H,2H2,1H3,(H2,14,15,16,17,18)
InChIKeyGAHFUKJFPSODTH-UHFFFAOYSA-N
XLogP14.14
TPSA328.07 Ų
H-Bond Donors9
H-Bond Acceptors23
Rotatable Bonds18
Heavy Atoms102
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001392.50
LogP ≤ 514.14
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1023

Analyze N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine?
The IUPAC name of N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine (CID 158195493) is N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine.
What is the SMILES notation for N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine?
The canonical SMILES for N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine is CCc1cc(Nc2nncc(-n3ccnc3)n2)n[nH]1.FC(F)(F)c1ccccc1-c1cc(Nc2n[nH]c3ccccc23)nnc1NCCN1CCCCC1.FC(F)(F)c1ccccc1-c1cnnc(Nc2n[nH]c3ccccc23)c1.c1nnc(Nc2cc(C3CCCC3)[nH]n2)nc1N1CCCC1.
What is the InChIKey of N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine?
The InChIKey is GAHFUKJFPSODTH-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H26F3N7.C18H12F3N5.C15H21N7.C11H12N8/c26-25(27,28)20-10-4-2-8-17(20)19-16-22(30-24-18-9-3-5-11-21(18)31-34-24)32-33-23(19)29-12-15-35-13-6-1-7-14-35;19-18(20,21)14-7-3-1-5-12(14)11-9-16(25-22-10-11)23-17-13-6-2-4-8-15(13)24-26-17;1-2-6-11(5-1)12-9-13(20-19-12)17-15-18-14(10-16-21-15)22-7-3-4-8-22;1-2-8-5-9(17-16-8)14-11-15-10(6-13-18-11)19-4-3-12-7-19/h2-5,8-11,16H,1,6-7,12-15H2,(H,29,33)(H2,30,31,32,34);1-10H,(H2,23,24,25,26);9-11H,1-8H2,(H2,17,18,19,20,21);3-7H,2H2,1H3,(H2,14,15,16,17,18).
What are the key properties of N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine?
N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine has a molecular weight of 1392.50 g/mol, XLogP of 14.14, 18 rotatable bonds, 9 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-cyclopentyl-1H-pyrazol-3-yl)-5-pyrrolidin-1-yl-1,2,4-triazin-3-amine;N-(5-ethyl-1H-pyrazol-3-yl)-5-imidazol-1-yl-1,2,4-triazin-3-amine;6-N-(1H-indazol-3-yl)-3-N-(2-piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyridazine-3,6-diamine;N-[5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine is sourced from PubChem (CID 158195493), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).